🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

115 results for “SINOVAC BIOTECH LTD” Clear

  1. Live attenuated varicella vaccine

    SINOVAC BIOTECH LTD

    Varicella

    approved mab active

    3 trials

  2. Mumps vaccine

    SINOVAC BIOTECH LTD

    Mumps

    approved mab completed

    1 trial

  3. Mumps vaccine, Live (MV)

    SINOVAC BIOTECH LTD

    Mumps

    approved mab active

    1 trial

  4. Pandemic influenza A/H1N1 vaccine

    SINOVAC BIOTECH LTD

    Influenza

    approved mab completed

    1 trial

  5. Quadrivalent Influenza Vaccine (Split Virion), inactivated

    SINOVAC BIOTECH LTD

    Seasonal Influenza

    approved mab completed

    1 trial

  6. SARS-CoV-2 Inactivated Vaccine

    SINOVAC BIOTECH LTD

    COVID-19

    approved mab active

    2 trials

  7. The live attenuated varicella vaccine and the inactivated hepatitis A vaccine

    SINOVAC BIOTECH LTD

    Varicella

    approved mab completed

    1 trial

  8. Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.

    SINOVAC BIOTECH LTD

    COVID-19

    approved mab completed

    1 trial

  9. Two doses of quadrivalent influenza vaccine

    SINOVAC BIOTECH LTD

    Seasonal Influenza

    approved mab completed

    1 trial

  10. Vaicella Vaccine+DTaP on Day 0, MMR on Day 30

    SINOVAC BIOTECH LTD

    Varicella (chickenpox)

    approved mab active

    1 trial

  11. Varicella vaccine

    SINOVAC BIOTECH LTD

    VZV

    approved mab completed

    1 trial

  12. Varicella vaccine+TIV

    SINOVAC BIOTECH LTD

    Varicella

    approved mab completed

    1 trial

  13. sIPV

    SINOVAC BIOTECH LTD

    Poliomyelitis

    approved mab active

    3 trials

  14. sIPV vaccine /DTaP vaccine

    SINOVAC BIOTECH LTD

    Poliomyelitis

    approved mab completed

    1 trial

  15. seasonal split influenza vaccine

    SINOVAC BIOTECH LTD

    Influenza

    approved mab completed

    1 trial

  16. split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose

    SINOVAC BIOTECH LTD

    Influenza

    approved mab completed

    1 trial

  17. trivalent seasonal influenza vaccine

    SINOVAC BIOTECH LTD

    Influenza

    approved mab completed

    1 trial

  18. SA58 Nasal Spray

    SINOVAC BIOTECH LTD

    COVID-19

    small molecule active

    2 trials

  19. Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses

    SINOVAC BIOTECH LTD

    Poliomyelitis

    mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources